PharmaCyte Biotech Inc (PMCB)

[Triple9]

We paid for a seat at the table and things are about to get very interesting and profitable, so of course Austrianova is going to re-negotiate. What choice does KW have, really, to only keep pancreatic cancer and let all other uses for CiaB get bought up by a European big pharma co? Do you want 90% of a small pie or 50% of a giant pie?

What I believe happened is PMCB got the attention of a US big pharma co at BIO. Austrianova was then approached by a European big pharma. Global big pharma is a small club and rumors spread very quickly.

I have no inside info. All I have is the text in the revised term sheet. Now, when negotiating, everything that ends up in the agreement is there for a specific reason. We can sort of reverse engineer the agreement by thinking about it in this way. You are too focused on %. Instead, focus on the material changes.

The non-disclosure clause added to the term sheet. Why was it added? So PMCB's US big pharma partner can be assured nothing is leaked to any European big pharm cos.

The right of first refusal clause added to the term sheet. Why was it added? So Austrianova can't sell everything when PMCB's Phase 2b returns some great top-line data.

Again, do you want 90% of a small pie or 50% of a massive pie?

I'm with KW here and my millions of shares have his full support.